Responses
Oral Presentations
Clinical trials addressing macrophage and chemokines in RA
OP0303 Mavrilimumab Reduces Pro-Inflammatory Cytokines and CD68 Positive Macrophages in Synovial Explants from Rheumatoid Arthritis Subjects Engrafted Into SCID/Beige Mice
Compose a Response to This Article
Other responses
No responses have been published for this article.